KLK6 and synucleinopathy: The authors concluded that altered CSF levels of α-synuclein and neurosin in patients with synucleinopathy versus AD mirror disease-specific neuropathological mechanisms that might be useful for the development of biomarkers specific for synucleinopathies [74].